Press Releases

December 5, 2023
Gossamer Bio Appoints Bob Smith as Chief Commercial Officer
- Mr. Smith is a recognized leader in the commercialization of PAH products, most recently leading sotatercept US pre-launch activities at Merck - - Previously, Mr. Smith led US sales operations for Actelion - SAN DIEGO --(BUSINESS WIRE)--Dec. 5, 2023-- Gossamer Bio, Inc.
Additional Formats
July 20, 2023
Gossamer Bio Announces $212 Million Private Placement Financing
- In Conjunction with Offering, Interim TORREY OLE Data and PROSERA Phase 3 Design Disclosed via 8-K; Conference Call to Discuss Data and Phase 3 Design with Leading PAH KOLs to be Held on July 25 th - SAN DIEGO --(BUSINESS WIRE)--Jul. 20, 2023-- Gossamer Bio, Inc.
Additional Formats
Displaying 1 - 10 of 12